相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling
Tian-Ying Jia et al.
EUROPEAN RADIOLOGY (2019)
Radiomics for the prediction of EGFR mutation subtypes in non-small cell lung cancer
Shu Li et al.
MEDICAL PHYSICS (2019)
Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning
Shuo Wang et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
Subba R. Digumarthy et al.
MEDICINE (2019)
A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer
Xin Chen et al.
ACADEMIC RADIOLOGY (2018)
Radiomics analysis of pulmonary nodules in low-dose CT for early detection of lung cancer
Wookjin Choi et al.
MEDICAL PHYSICS (2018)
Comprehensive Computed Tomography Radiomics Analysis of Lung Adenocarcinoma for Prognostication
Geewon Lee et al.
ONCOLOGIST (2018)
Detection of epithelial growth factor receptor (EGFR) mutations on CT images of patients with lung adenocarcinoma using radiomics and/or multi-level residual convolutionary neural networks
Xiao-Yang Li et al.
JOURNAL OF THORACIC DISEASE (2018)
Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival rates
B. Sacconi et al.
CLINICAL RADIOLOGY (2017)
The Eighth Edition Lung Cancer Stage Classification
Frank C. Detterbeck et al.
CHEST (2017)
Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas
Ying Liu et al.
CLINICAL LUNG CANCER (2016)
Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes
Su Jin Hong et al.
EUROPEAN RADIOLOGY (2016)
Fusion of Quantitative Image and Genomic Biomarkers to Improve Prognosis Assessment of Early Stage Lung Cancer Patients
Nastaran Emaminejad et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2016)
Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer
Yanqi Huang et al.
RADIOLOGY (2016)
Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology
Weimiao Wu et al.
FRONTIERS IN ONCOLOGY (2016)
Lung cancer epidemiology: contemporary and future challenges worldwide
Joanna Didkowska et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer
Wei Sun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Use of Research Biopsies in Clinical Trials: Are Risks and Benefits Adequately Discussed?
Michael J. Overman et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer
Hua Bai et al.
PLOS ONE (2013)
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell et al.
LANCET ONCOLOGY (2012)
EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study
Ramon Andrade de Mello et al.
TUMOR BIOLOGY (2012)
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS)
Masahiro Fukuoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data
J Gui et al.
BIOINFORMATICS (2005)
分享论文
